Black Rock Inc. Recursion Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 17,310,162 shares of RXRX stock, worth $125 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,310,162

Previous 12,321,035 40.49%

Holding current value

$125 Million

Previous $123 Million 5.69%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$7.35 - $10.05 $36.7 Million - $50.1 Million	4,989,127 Added 40.49%	17,310,162 $130 Million
Q1 2024 May 10, 2024	SELL	$9.13 - $15.52 $665,001 - $1.13 Million	-72,837 Reduced 0.59%	12,321,035 $123 Million
Q4 2023 Feb 13, 2024	BUY	$5.09 - $10.79 $2.73 Million - $5.79 Million	536,918 Added 4.53%	12,393,872 $122 Million
Q3 2023 Nov 13, 2023	BUY	$6.59 - $15.86 $1.57 Million - $3.77 Million	237,527 Added 2.04%	11,856,954 $90.7 Million
Q2 2023 Aug 11, 2023	BUY	$4.56 - $9.94 $4.5 Million - $9.82 Million	987,570 Added 9.29%	11,619,427 $86.8 Million
Q1 2023 May 12, 2023	SELL	$6.42 - $9.64 $229,624 - $344,793	-35,767 Reduced 0.34%	10,631,857 $70.9 Million
Q4 2022 Feb 13, 2023	BUY	$7.16 - $12.7 $6.45 Million - $11.4 Million	900,584 Added 9.22%	10,667,624 $82.2 Million
Q3 2022 Nov 14, 2022	BUY	$7.83 - $13.6 $11.9 Million - $20.7 Million	1,525,258 Added 18.51%	9,767,040 $104 Million
Q2 2022 Aug 12, 2022	BUY	$5.04 - $9.26 $7.73 Million - $14.2 Million	1,534,025 Added 22.87%	8,241,782 $67.1 Million
Q1 2022 May 12, 2022	SELL	$6.16 - $18.03 $338,350 - $990,333	-54,927 Reduced 0.81%	6,707,757 $48 Million
Q4 2021 Feb 10, 2022	BUY	$16.14 - $21.86 $80.6 Million - $109 Million	4,995,020 Added 282.58%	6,762,684 $116 Million
Q3 2021 Nov 09, 2021	BUY	$19.03 - $41.33 $6.16 Million - $13.4 Million	323,586 Added 22.41%	1,767,664 $40.7 Million
Q2 2021 Aug 11, 2021	BUY	$18.0 - $37.42 $26 Million - $54 Million	1,444,078 New	1,444,078 $52.7 Million

Others Institutions Holding RXRX

# of Institutions

286

Shares Held

242M

Call Options Held

1.35M

Put Options Held

2.32M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.31B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account